Introduction
Introduction

Structural and functional analysis of the human genome has revealed that cis-regulatory elements influencing transcription often exist some distance away from relevant basal promoters. These elements may include enhancers, silencers, insulators and locus control regions. Large-scale, functional genomics efforts such as the ENCyclopedia Of DNA Elements (ENCODE) project
have begun to annotate the broader context of the human genome by locating and defining these embedded regulatory elements. The cystic fibrosis transmembrane conductance regulator gene (CFTR) , which when mutated causes the common genetic disease cystic fibrosis, is associated with a number of potential cis-regulatory sites. These elements often display specific changes in local chromatin structure, and we have previously evaluated the CFTR locus in many cell types for structural features including histone modifications, DNase I hypersensitivity and associated transcription factor binding [2] [3] [4] [5] [6] . Here, we use a high-resolution, tiled microarray-based assay, DNase-chip [7] , to map DNase Ihypersensitive site (DHS) within 90 kb flanking the CFTR promoter region. We detected a cell-type-specific DHS within the first intron of CFTR that corresponds to a regulatory element that we identified in earlier work [8, 9] and has been confirmed by others [10] . This element (known as 7/8 based on primer sets used to amplify the region [9] ) was shown to positively regulate CFTR promoter activity specifically in intestinal cells both in vitro and in vivo. [8] . Nonetheless, the mechanism of action of this key regulatory element has not yet been explored.
Removal of the element from a human CFTR yeast artificial chromosome (YAC) reduced expression levels of the human gene by about 60% in transgenic mice carrying the YAC but only within the epithelium of the small intestine
We now utilize this element in transient transfection experiments to show that it functions as a classical, tissue-specific enhancer and can also independently recruit general factors necessary for transcription initiation. To determine the nuclear factor(s) interacting with the regulatory sequence, we perform in
vitro DNase I footprinting analysis, which reveals a significant protected sequence within which exists a conserved hepatocyte nuclear factor 1 (HNF1) binding site. Expression of HNF1␣ correlates with CFTR expression, and this transcription factor binds in vitro to another cluster of intronic DHS in CFTR [11] . In vivo, HNF1␣ contributes to the maintenance of normal mouse CFTR expression levels in the small intestine [11] . Here, we show that HNF1 binds to the intron 1 
enhancer both in vitro, by electrophoretic mobility shift assay (EMSA), and in vivo, by chromatin immunoprecipitation (ChIP). Moreover, we use chromosome conformation capture (3C) analysis to show that this intronic enhancer interacts with the CFTR promoter in vivo, revealing a three-dimensional structure of the active CFTR locus.
Methods
Cell culture
The human colon carcinoma cell lines Caco2 [12] and HT29 [13] , human bronchial epithelial cell line 16HBE14o- [14] and the human embryonic kidney cell line HEK293 [15] 
DNase-chip
DNase-chip was performed as previously described, with modifications [7] . Briefly, 2- Transcription kit (Applied Biosystems). CFTR expression was assayed using E1 primer set [17] ; as a control, ␤-glucocerebrosidase (GenBank no. M16328) expression was assayed using primers GD67A and GD9B (11) .
Plasmid construction
PCR amplification of the CFTR basal promoter and intron 1 putative regulatory elements (referred to as 7/8) was described previously [9] . [9] . 
In vitro transcription/translation of HNF1
Electrophoretic mobility shift assays
Complementary single-stranded oligonucleotides (see Fig. 4 
Chromatin immunoprecipitation (ChIP)
Chromosome conformation capture (3C)
Chromosome conformation capture (3C) was performed as described previously [18, 19] [20] [21] [22] . (Fig. 1A) . (Fig. 2B) (Fig. 3B) (Fig. 4A) . The specificity of DNA-protein interactions with HNF1 was confirmed using a probe with a 2 bp mutation within the core of the HNF1-binding site. Pre-incubation of the nuclear extracts with the mutated unlabelled probe competitor had no effect on complex A, suggesting that binding of these factors to DNA requires an intact HNF1-binding motif (Fig. 4A) (Fig. 5) . The ␣1-antitrypsin (AAT) promoter provided a positive control for HNF1 binding [24, 25] Destroying the HNF1-binding site abrogates enhancer and 'promoter' activity of 7/8
Results
A tissue-specific DHS exists 10 kb into the first intron of CFTR
Fig. 1 DNase-chip detects cell-type-specific DHS 10 kb into the first intron of CFTR. (A) Shown are DHS tracks in four different cell types: CFTR-primary human skin fibroblasts, CFTRϩ human bronchial epithelial cell line 16HBE14o-and CFTRϩ human colon carcinoma cell lines Caco2 and HT29. Significant peaks representing DHS are apparent in the 5Ј promoter region of CFTRϩ cells, whereas Caco2 and HT29 cells display another significant DHS within the first intron. Peak height is a measurement of -log10 (P-value) between 0 and 16, as determined by ACME (see Methods
HNF1 binds an element within the CFTR intron 1 DHS in vitro and in vivo Previous studies demonstrated that the 185 ϩ 10 kb DHS element binds specific protein complexes in Caco2 cells, though the identity of the factors was not revealed. To identify potential transcription factor-binding sites across the DHS 185 ϩ 10 kb region, in vitro DNase I footprinting was performed (Fig. 3A). Two protected regions were evident upon binding of Caco2 nuclear extracts to a radiolabelled probe spanning the sense strand of 7/8. The protected regions encompass 30 (footprint 1, FP1) and 23 (footprint 2, FP2) nucleotide sequences and suggest a complex pattern of DNA-protein interactions within this site. These data are consistent with footprints identified in our previous analysis of this region, utilizing, in addition to Caco2 cells, nuclear extracts from primary male genital duct epithelial cells [9]. At the time of the original analysis, we were unable to predict the candidate transcription factors involved at this site due to the relative paucity of defined binding sites in available databases. We again performed in silico analysis for putative transcription factor-binding sites using MatInspector (http://www.genomatix.de). Within FP1, a strong predicted binding site for HNF1, which recognizes the consensus sequence GTTAATNATTANC [23], was identified on the antisense strand and it resides within a region of high sequence conservation between a number of species
In Fig. 4 , we showed that the alteration of two bases in the consensus binding site for HNF1 abolished protein-DNA interactions
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Fig. 3 In vitro DNase I footprinting of 7/8 enhancer reveals two distinct protected regions. (A) A/G ladder used as reference (first lane); samples incubated with increasing amounts of Caco2 nuclear extracts (NE) and radiolabelled sense strand of 7/8 sequence. Lanes with NE alone and DNase I alone were used as controls. (B) Sequence corresponding to the two protected regions. Conservation track based on phastCons MultiZ alignment of 17 vertebrate species, available on ENCODE browser (http://www.genome.ucsc.edu/ENCODE). In silico analysis revealed a highly conserved HNF1 site on the antisense strand within FP1.
in EMSA experiments. Next, we mutated the same two bases within the HNF1-binding site in fragment 7/8 cloned into either the enhancer or the promoter site of the pGL3 reporter vector and assayed them for activity (Fig. 6) . Figure 6 shows that destruction of the HNF1 site completely abolishes both the enhancer (Fig. 6A) and the 'promoter' (Fig. 6B) [50] . This element likely corresponds to the weak DHS that we observed previously at 185 ϩ 12 kb [9] . Yet 
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